BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8189546)

  • 1. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.
    Posavad CM; Newton JJ; Rosenthal KL
    J Virol; 1994 Jun; 68(6):4072-4. PubMed ID: 8189546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.
    Posavad CM; Newton JJ; Rosenthal KL
    J Immunol; 1993 Nov; 151(9):4865-73. PubMed ID: 8409445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
    Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
    Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.
    Jerome KR; Tait JF; Koelle DM; Corey L
    J Virol; 1998 Jan; 72(1):436-41. PubMed ID: 9420243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity.
    Aubert M; Krantz EM; Jerome KR
    Viral Immunol; 2006; 19(3):391-408. PubMed ID: 16987059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
    Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
    Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes.
    Posavad CM; Koelle DM; Corey L
    J Virol; 1996 Nov; 70(11):8165-8. PubMed ID: 8892947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
    J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.
    Posavad CM; Rosenthal KL
    J Virol; 1992 Nov; 66(11):6264-72. PubMed ID: 1328666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
    Tigges MA; Leng S; Johnson DC; Burke RL
    J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
    Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z; Cunningham AL
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
    Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.
    Zhang X; Issagholian A; Berg EA; Fishman JB; Nesburn AB; BenMohamed L
    J Virol; 2005 Dec; 79(24):15289-301. PubMed ID: 16306600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.
    Yasukawa M; Shiroguchi T; Kobayashi Y
    Infect Immun; 1983 Apr; 40(1):190-7. PubMed ID: 6187690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.